For more information, please contact: Karin Almqvist Liwendahl Chief Financial Officer [email protected] +46 709 11 56 08
Immunovia in brief
Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection. Immunovia is focused on the development and commercialization of simple blood-based testing to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer.
Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer.
USA is the world's largest market for detection of pancreatic cancer. The company estimates that in the USA, 1.8 million individuals are at high-risk for pancreatic cancer and could benefit from annual surveillance testing.
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit?www.immunovia.com
KRAFTON Inc. (CEO CH Kim, KRX: 259960) announced its 1Q24 preliminary earnings on May 8.
KRAFTON recorded its 1Q24 sales of 665.9B South Korean Won, Operating Profit (OP) of 310.5B KRW, and Net Profit (NP) of 348.6B KRW following the Korean...
Genesis Land Development Corp. ("Genesis") is pleased to report that at its annual meeting of shareholders held on May 14, 2024 that each of the nominees proposed by management as a director of Genesis were elected as directors.
The detailed...
Nexus Industrial REIT (the "REIT") announced today its results for the first quarter ended March 31, 2024. "This quarter we continued to make progress as a Canada-focused pure-play industrial REIT" commented Kelly Hanczyk, CEO of Nexus...
Mason Capital Management LLC, a Delaware limited liability company ("Mason Capital"), announced today that it has commenced a tender offer (the "Tender Offer") for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the...
Braemar Hotels & Resorts Inc. ("Braemar" or the "Company") today announced that, based on estimated preliminary results, Blackwells Capital LLC's ("Blackwells") withhold proxy campaign at Ashford Hospitality Trust, Inc. ("Ashford Trust") proved to...
Ashford Hospitality Trust, Inc. ("Ashford Trust" or the "Company") is pleased to report estimated preliminary results of its 2024 Annual Meeting of Stockholders and noted that Blackwells Capital LLC's ("Blackwells") attempted withhold proxy campaign...